H.C. Wainwright analyst Swayampakula Ramakanth maintained a Buy rating on AVEO Pharma (AVEO – Research Report) today and set a price target of $19.00. The company's shares closed last Tuesday at $4.27. According to TipRanks.com, Ramakanth is a 1-star analyst with an average return of -2.0% and a 32.4% success rate. Ramakanth covers the Healthcare sector, focusing on stocks such as Diffusion Pharmaceuticals, Corvus Pharmaceuticals, and Janux Therapeutics Inc. Currently, the analyst consensus on AVEO Pharma is a Strong Buy with an average price target of $14.67.
https://www.tipranks.com/news/blurbs/h-c-wainwright-keeps-their-buy-rating-on-aveo-pharma-aveo-2?utm_source=advfn.com&utm_medium=referral
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Oct 2022 to Nov 2022 Click Here for more AVEO Pharmaceuticals Charts.
AVEO Pharmaceuticals (NASDAQ:AVEO)
Historical Stock Chart
From Nov 2021 to Nov 2022 Click Here for more AVEO Pharmaceuticals Charts.